X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
indolent systemic mastocytosis (67) 67
humans (65) 65
index medicus (65) 65
mastocytosis (48) 48
allergy (37) 37
immunology (37) 37
female (32) 32
anaphylaxis (31) 31
adult (30) 30
male (30) 30
systemic mastocytosis (26) 26
middle aged (25) 25
tryptase (25) 25
mast cell disease (24) 24
mutation (22) 22
animals (21) 21
urticaria pigmentosa (20) 20
diagnosis (19) 19
mastocytosis - diagnosis (18) 18
osteoporosis (18) 18
aged (17) 17
cutaneous mastocytosis (17) 17
anaphylaxis - immunology (16) 16
hematology (16) 16
immunotherapy (16) 16
hymenoptera venom allergy (15) 15
allergy and immunology (14) 14
mastocytosis - immunology (14) 14
tryptases - blood (14) 14
hymenoptera - immunology (13) 13
mast cells - immunology (13) 13
proto-oncogene proteins c-kit - genetics (13) 13
bone-marrow (12) 12
mast cells - pathology (12) 12
mastocytosis, systemic - diagnosis (12) 12
young adult (12) 12
analysis (11) 11
indolent (11) 11
mast cell (11) 11
mast-cell disease (11) 11
mastocytosis, systemic - pathology (11) 11
pediatric mastocytosis (11) 11
arthropod venoms - immunology (10) 10
bone density (10) 10
c-kit (10) 10
c-kit mutation (10) 10
dermatology (10) 10
mast cells - metabolism (10) 10
patients (10) 10
risk factors (10) 10
serum tryptase (10) 10
allergies (9) 9
basal serum tryptase (9) 9
biopsy (9) 9
bone marrow (9) 9
disease (9) 9
insect bites and stings - immunology (9) 9
mast cell activation syndrome (9) 9
mast cells (9) 9
mastocytosis - complications (9) 9
mastocytosis - epidemiology (9) 9
mastocytosis - therapy (9) 9
medicine & public health (9) 9
venom (9) 9
venom immunotherapy (9) 9
allergens - immunology (8) 8
care and treatment (8) 8
classification (8) 8
mast-cell disorders (8) 8
mast-cells (8) 8
medicine, general & internal (8) 8
prevalence (8) 8
prognosis (8) 8
skin (8) 8
spanish network (8) 8
abridged index medicus (7) 7
anaphylaxis - diagnosis (7) 7
anaphylaxis - etiology (7) 7
biomarkers (7) 7
consensus proposal (7) 7
criteria (7) 7
fractures (7) 7
kit d816v (7) 7
leukemia (7) 7
mast-cell tryptase (7) 7
mastocytosis, systemic - drug therapy (7) 7
mastocytosis, systemic - genetics (7) 7
retrospective studies (7) 7
tryptase levels (7) 7
urticaria-pigmentosa (7) 7
adolescent (6) 6
blood (6) 6
bone mineral density (6) 6
indolent mastocytosis (6) 6
interferon-alpha (6) 6
internal medicine (6) 6
kit d816v mutation (6) 6
mastocytosis, systemic - immunology (6) 6
mastocytosis, systemic - therapy (6) 6
oncology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 08/2014, Volume 166, Issue 4, pp. 521 - 528
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2009, Volume 124, Issue 3, pp. 514 - 521
Background Indolent systemic mastocytosis is a group of rare diseases for which reliable predictors of progression and outcome are still lacking. Objective... 
Allergy and Immunology | Mastocytosis | indolent systemic mastocytosis | long-term prognosis | CRITERIA | RESPONSIVENESS | TRYPTASE LEVELS | CATALYTIC DOMAIN | C-KIT | HEMATOLOGIC DISORDER | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | MAST-CELL DISEASE | ALLERGY | MUTATION | IMATINIB | Multivariate Analysis | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Proto-Oncogene Proteins c-kit - immunology | Recombinant Proteins | Proto-Oncogene Proteins c-kit - metabolism | Enzyme Inhibitors - administration & dosage | Young Adult | beta 2-Microglobulin - blood | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Retrospective Studies | Enzyme Inhibitors - adverse effects | Mast Cells - immunology | Antiviral Agents - therapeutic use | Mastocytosis, Systemic - drug therapy | Interferon-alpha - therapeutic use | Hydroxyurea - administration & dosage | Antiviral Agents - administration & dosage | Enzyme Inhibitors - therapeutic use | Disease Progression | Interferon-alpha - administration & dosage | Hydroxyurea - adverse effects | Mastocytosis, Systemic - mortality | Antiviral Agents - adverse effects | Adolescent | Mastocytosis, Systemic - pathology | Hydroxyurea - therapeutic use | Aged | Interferon-alpha - adverse effects | Medicine, Experimental | Medical research | Development and progression | Mast cell disease | Leukemia | Heart attacks | Medical imaging | Disease | Multivariate analysis | Patients | Studies | Osteoporosis | Biopsy | Medical prognosis | Classification | Tomography | Mutation | Age | Index Medicus | Abridged Index Medicus
Journal Article
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, ISSN 0012-0472, 08/2014, Volume 139, Issue 31-32, pp. 1572 - 1575
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2016, Volume 91, Issue 7, pp. 654 - 655
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 11/2015, Volume 141, Issue 11, pp. 2047 - 2060
Journal Article
Hematology, ISSN 1024-5332, 10/2017, Volume 22, Issue 9, pp. 544 - 547
Objectives: Systemic mastocytosis (SM) is a myeloproliferative disease characterized by the accumulation of aberrant mast cells. Since advanced subtypes of SM... 
hepatosplenomegaly | Indolent | abdominal | mastocytosis | ultrasonography | tryptase | HEMATOLOGY | Splenomegaly | Follow-Up Studies | Humans | Middle Aged | Abdominal Cavity - pathology | Male | Workflow | Abdominal Cavity - diagnostic imaging | Mastocytosis, Systemic - diagnostic imaging | Hepatomegaly | Ultrasonography | Mastocytosis, Systemic - pathology | Female | Aged | Disease Management
Journal Article
Dermatology Reports, ISSN 2036-7392, 2014, Volume 6, Issue 1, p. 5199
Systemic mastocytosis (SM) is a rare, heterogeneous disorder characterized by infiltration and accumulation of mast cells within multiple organs, most commonly... 
Urticaria pigmentosa | Mastocytosis | Indolent systemic masocytosis | Darier's sign | mastocytosis, indolent systemic masocytosis, urticaria pigmentosa, Darier's sign
Journal Article
European Review for Medical and Pharmacological Sciences, ISSN 1128-3602, 2015, Volume 19, Issue 9, pp. 1607 - 1609
From a dermatological aspect, it posed a considerable challenge the skin-limited form of mastocytosis, urticaria pigmentosa and indolent systemic mastocytosis... 
Indolent systemic mastocytosis | Tyrosine kinase inhibitor | KIT D816V mutation | Myeloproliferative neoplasm | Imatinib mesylate | KIT MUTATION | PHARMACOLOGY & PHARMACY
Journal Article
Annals of Gastroenterology, ISSN 1108-7471, 2014, Volume 27, Issue 3, pp. 270 - 272
Systemic mastocytosis is a clonal disorder of the mast cell and its progenitor cell. It is a rare disorder with unknown incidence in Greece, with an estimate... 
Mastocytosis | Indolent | Asymptomatic | Colitis | Ileitis | indolent | colitis | ileitis | asymptomatic | Case Report
Journal Article